Biopharmaceutical classification system - experimental model ofthe prediction of drug bioavailability

   


1. A.V. BOGATSKY PHYSICO-CHEMICAL INSTITUTE OF THE NATIONAL ACADEMY OF SCIENCES OF UKRAINE
Type: Review
UDK: 615.015.4      PubMed Id: 18988456
Year: 2008 vol: 54  issue:4  pages: 392-407
Abstract: Biopharmaceutical classification system (BCS) is based on solubility tests; for various drugs they correlate with their bioavailability in human body. It is widely used in design and development of innovation drugs, new dosage forms (permeability amplifiers), in clinical pharmacology (drug-drug, drug-food interaction) and also by regulation agencies of several countries as the scientific approach, for testing of waiver on bioavailability.Review considers modern concepts and theoretical bases for prediction of bioavailability according to BCS. It gives characteristics of fundamental parameters of the system: absorption number, solubility number and the ratio of dose to the soluble part of the drug. Possible versions of BCS modification for its subsequent optimization are discussed.
Download PDF:
Reference: Golovenko N.Y., Borisuk I.U., Biopharmaceutical classification system - experimental model ofthe prediction of drug bioavailability, Biomeditsinskaya khimiya, 2008, vol: 54(4), 392-407.
This paper is also available as the English translation:10.1134/S1990750808030037
Bibliography
 2016(Vol:62)
 2015(Vol:61)
 2014(Vol:60)
 2013(Vol:59)
 2012(Vol:58)
 2011(Vol:57)
 2010(Vol:56)
 2009(Vol:55)
 2008(Vol:54)
 2007(Vol:53)
 2006(Vol:52)
 2005(Vol:51)
 2004(Vol:50)
 2003(Vol:49)